Neko's $700M wager: can AI body scans disrupt US healthcare?

neko health secured $700m in series c funding led by lightspeed and o.g. venture partners to establish its first us clinic in new york, utilizing a proprietary platform that blends medical imaging, blood analysis, and clinician review. this massive capital injection indicates that investors believe scalable, ai-driven preventive screening can overhaul the reactive nature of current healthcare systems. the expansion poses a challenge to established diagnostic providers by emphasizing early detection over treatment, potentially forcing the industry to adopt more automated, data-first screening tools.